AUS
NZ
UK
CA
USA
IND
Healt
Fisher & Paykel (ASX: FPH) Updates Profit Forecast for FY25
August 23, 2024 10:34 AM AEST| By Team Kalkine MediaFisher & Paykel Healthcare Corporation Ltd (ASX: FPH) has revised its profit forecast for the fiscal year 2025, anticipating a net profit after tax (NPAT) of between $320 million and $370 million. This forecast represents an increase from the previou...
Clarity Pharmaceuticals and Next Science: Key Updates in the Biotech Sector
August 22, 2024 06:25 PM AEST| By Team Kalkine MediaClarity Pharmaceuticals,(ASX: CU6),has received a significant boost with the FDA granting 'Fast Track' designation to its new imaging agent, 64Cu-SAR-bisPSMA, designed for detecting prostate cancer. This designation is set to accelerate the developme...
US FDA Grants Fast Track Status to Clarity Pharma’s (ASX:CU6) Innovative Prostate Cancer PET Imaging Compound
August 22, 2024 11:57 AM AEST| By Team Kalkine MediaHighlights:,FDA Fast Track Status,:,Clarity Pharmaceuticals has received fast track status from the US FDA for its prostate cancer imaging compound, 64Cu-SAR-bisPSMA, which is designed for PET scans.,Accelerated Approval,:,The,fast track,designation...
Osteopore (ASX:OSX) Completes 3D-Printed Bone Implant Study Funded by Chilean Government
August 22, 2024 10:30 AM AEST| By Team Kalkine MediaOsteopore Limited (ASX:OSX),has successfully concluded a research program funded by the Chilean government, focused on developing a 3D-printed bone implant designed to enhance regenerative healing. This research marks a significant milestone for the...
Healius Ltd (ASX:HLS) Shares Surge 9% After Full-Year Results Amidst ASX 200 Decline
August 21, 2024 02:57 PM AEST| By Team Kalkine MediaHealius Ltd (ASX:HLS), a prominent player in the pathology and imaging sector, is enjoying a notable boost in its share price today. While the S&P/ASX 200 Index (ASX: XJO) has dipped by 0.5%, Healius shares have surged by 8.8%, climbing to AU$1.60 fr...
EBOS Group (ASX:EBO)Sees Bright Future Despite Recent Setbacks
August 21, 2024 11:48 AM AEST| By Team Kalkine MediaEBO.AX: EBOS Group (ASX:EBO), the New Zealand-based healthcare and pet products company, is moving forward with renewed confidence after a successful year. Despite a failed attempt to acquire Greencross in late 2023, EBOS has reported record sales an...
Healius Suspends Dividend Amid Increased Losses
August 21, 2024 11:02 AM AEST| By Team Kalkine MediaHealius Ltd, a prominent,ASX healthcare stock,in the Australian pathology sector, has recently released its financial results for the fiscal year 2024 (FY24), revealing a challenging year marked by deepened losses. Despite a modest increase in revenu...
INOVIQ (ASX:IIQ) Announces Blood Test for Parkinson’s Disease, Building on Alzheimer’s Success
August 20, 2024 11:27 AM AEST| By Team Kalkine MediaINOVIQ (ASX:IIQ) saw its shares rise by 6% on Tuesday following the company’s announcement of a breakthrough in blood testing for Parkinson’s Disease (PD). This new development comes on the heels of a similar success with Alzheimer’s Disease (AD) rep...
ASX Health Stocks: LTR Pharma’s ED Therapy Advances Under TGA Scheme
August 16, 2024 05:26 PM AEST| By Team Kalkine MediaLTR Pharma Ltd (ASX:LTP) has reached a significant milestone in the launch of its nasal spray treatment for erectile dysfunction (ED), with the first select group of patients receiving Spontan under the Therapeutic Goods Administration (TGA) Authoris...
Cochlear Ltd (ASX: COH) Faces Share Price Drop Despite Positive Results
August 16, 2024 01:47 PM AEST| By Team Kalkine MediaCochlear Ltd, a prominent player in the hearing implant sector, saw its share price fall by 7% following the release of its financial results for the fiscal year 2024 (FY24). Despite reporting robust financial and operational performance for the year...
Wellnex (ASX:WNX) Announces First Special Access Scheme Prescriptions for New Wellness Life Brand
August 16, 2024 10:09 AM AEST| By Team Kalkine MediaWellnex (ASX:WNX) has reached a significant milestone with the launch of its Wellness Life brand, now available through the Therapeutic Goods Administration's (TGA) Special Access Scheme (SAS). This marks the first set of prescriptions for Wellness L...
Cochlear (ASX:COH) Shares Dive After Disappointing Profit Forecast
August 15, 2024 12:26 PM AEST| By Team Kalkine MediaShares in Cochlear (ASX:COH) plummeted over 8% on Thursday after the Australian hearing implants maker revealed a profit forecast for the current fiscal year that fell short of market expectations. This unexpected forecast prompted a sharp sell-off,...
Pro Medicus Ltd (ASX: PME) Share Price Soars After Impressive FY24 Results
August 14, 2024 04:59 PM AEST| By Team Kalkine MediaPro Medicus Ltd,(ASX: PME),is enjoying a notable boost in its share price, which has risen by 8% following the release of its robust FY24 financial results. The company, renowned for its expertise in healthcare informatics, offers a comprehensive sui...
Immutep (ASX: IMM) Doses First Human Patient with IMP761 – Potential Broad-Spectrum Autoimmune Treatment
August 14, 2024 10:33 AM AEST| By Team Kalkine MediaHighlights:,First,Human Dosing of IMP761,:,Immutep,(ASX: IMM) has,initiated,its first human trial for IMP761, a new autoimmune treatment based on LAG-3, aiming to modulate malfunctioning T cells associated with autoimmune diseases.,Targeted,Autoimmun...
Anteris Technologies, LTR Pharma, and CSL Boost ASX with Worthfull Results
August 13, 2024 05:42 PM AEST| By Team Kalkine MediaAnteris Technologies,(ASX: AVR),is set to relocate its headquarters to the United States, transitioning to Anteris Technologies Global Corp. (Holdco). This strategic move involves a re-domiciliation process where Holdco will become the new parent com...
CSL Experiences Notable Drop Amid Slower Revenue Projections
August 13, 2024 11:44 AM AEST| By Team Kalkine MediaShares of CSL Ltd,(ASX:CSL),, a leading player in the global biotechnology sector, experienced a sharp decline on Monday, falling by 2.8%. This drop marks CSL's most substantial single-day decline since February of this year. The decline comes amidst...
CSL Ltd (ASX:CSL) Share Price Takes a Hit Amidst Mixed FY24 Results
August 13, 2024 10:35 AM AEST| By Team Kalkine MediaOn Tuesday morning, CSL Ltd (ASX: CSL) is facing significant pressure on its share price, reflecting a cautious investor sentiment following the release of its full-year results for FY 2024. Despite showing strong performances across its business seg...
CSL Ltd (ASX: CSL) Reports 20% Increase in Net Profit, Maintains Positive Outlook
August 13, 2024 10:16 AM AEST| By Team Kalkine MediaCSL Ltd,(ASX: CSL),, a leading player in the biotechnology sector, has announced a robust 20% increase in its net profit for the 2024 financial year. This significant rise underscores the company's successful efforts in reviving its core plasma colle...
Psilocybin Drug Shows Promise for Fibromyalgia Pain Relief in ASX Health Stocks
August 12, 2024 04:13 PM AEST| By Team Kalkine MediaTryptamine Therapeutics shows promise for fibromyalgia with its psilocybin treatment. Actinogen Medical reports mixed results for its depression drug, Xanamem. PYC Therapeutics sees notable vision improvements with VP-001 for Retinitis Pigmentosa typ...
ASX Health Stocks: Neuren’s Angelman Drug Positive, Share Price Falls
August 09, 2024 04:45 PM AEST| By Team Kalkine MediaNeuren Pharmaceuticals Ltd,(ASX: NEU),has shared promising results from its Phase 2 clinical trial of NNZ-2591, a drug designed to treat Angelman syndrome, a rare genetic disorder affecting the nervous system. The trial, which involved children aged...
Advertise your brand on Kalkine Media